一项回顾性观察性研究:在手术室和介入放射室进行化疗口植入术的结果比较。

IF 1.2 4区 医学 Q3 SURGERY
Yong-Man Park, Donghyoun Lee, Jaemin Jo, Won-Bae Chang
{"title":"一项回顾性观察性研究:在手术室和介入放射室进行化疗口植入术的结果比较。","authors":"Yong-Man Park, Donghyoun Lee, Jaemin Jo, Won-Bae Chang","doi":"10.4174/astr.2025.108.6.362","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Chemo-port insertion is performed by a radiologist or surgeon in an interventional radiology (IR) suite or an operating room (OR). The complication rate is approximately 3%-4%. However, there is still a lack of data for comparison when it is performed in different conditions such as IR suite and OR.</p><p><strong>Methods: </strong>This study is for the safety of adult cancer patients after chemo-port implantation by comparing postoperative complication types and rates in different places. Among 375 patients who underwent chemo-port implantation, 203 patients underwent chemo-port implantation by radiologists in an IR suite, and 172 patients underwent the procedure by general surgeons in an OR. In both groups, early and late mortality were investigated. Early and late complication types and rates were also compared, and our study results were compared to the literature.</p><p><strong>Results: </strong>Patients' characteristics showed no differences. Mortality after the procedure was 39 in OR <i>vs.</i> 72 in IR (P < 0.01). Early mortality at 7 days was 1 in IR, no patient in OR (P = 0.36). Catheter problems did not show a statistical difference in these 2 groups (1.16% <i>vs.</i> 0.49%, P = 0.47). Venous thrombosis happened in 4 and 7 (2.33% <i>vs.</i> 3.45%, P = 0.13), and the central line bloodstream infection was in 5 patients and 6 patients (2.91% <i>vs.</i>. 2.96%, P = 0.98), respectively. Skin problems were 6 and 7 (3.49% <i>vs.</i> 3.45%, P = 0.98). Port site infection happened in 6 patients in each group (3.49% <i>vs.</i> 2.96%, P = 0.77).</p><p><strong>Conclusion: </strong>Chemo-port implantation can be performed in OR or IR without difference in complication rates.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"108 6","pages":"362-366"},"PeriodicalIF":1.2000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12149993/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparison of outcomes for chemo-port implantation performed in the operating room and interventional radiology suite: a retrospective observational study.\",\"authors\":\"Yong-Man Park, Donghyoun Lee, Jaemin Jo, Won-Bae Chang\",\"doi\":\"10.4174/astr.2025.108.6.362\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Chemo-port insertion is performed by a radiologist or surgeon in an interventional radiology (IR) suite or an operating room (OR). The complication rate is approximately 3%-4%. However, there is still a lack of data for comparison when it is performed in different conditions such as IR suite and OR.</p><p><strong>Methods: </strong>This study is for the safety of adult cancer patients after chemo-port implantation by comparing postoperative complication types and rates in different places. Among 375 patients who underwent chemo-port implantation, 203 patients underwent chemo-port implantation by radiologists in an IR suite, and 172 patients underwent the procedure by general surgeons in an OR. In both groups, early and late mortality were investigated. Early and late complication types and rates were also compared, and our study results were compared to the literature.</p><p><strong>Results: </strong>Patients' characteristics showed no differences. Mortality after the procedure was 39 in OR <i>vs.</i> 72 in IR (P < 0.01). Early mortality at 7 days was 1 in IR, no patient in OR (P = 0.36). Catheter problems did not show a statistical difference in these 2 groups (1.16% <i>vs.</i> 0.49%, P = 0.47). Venous thrombosis happened in 4 and 7 (2.33% <i>vs.</i> 3.45%, P = 0.13), and the central line bloodstream infection was in 5 patients and 6 patients (2.91% <i>vs.</i>. 2.96%, P = 0.98), respectively. Skin problems were 6 and 7 (3.49% <i>vs.</i> 3.45%, P = 0.98). Port site infection happened in 6 patients in each group (3.49% <i>vs.</i> 2.96%, P = 0.77).</p><p><strong>Conclusion: </strong>Chemo-port implantation can be performed in OR or IR without difference in complication rates.</p>\",\"PeriodicalId\":8071,\"journal\":{\"name\":\"Annals of Surgical Treatment and Research\",\"volume\":\"108 6\",\"pages\":\"362-366\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12149993/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Surgical Treatment and Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4174/astr.2025.108.6.362\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Surgical Treatment and Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4174/astr.2025.108.6.362","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

目的:化疗端口插入由放射科医生或外科医生在介入放射(IR)套房或手术室(or)进行。并发症发生率约为3%-4%。然而,在IR套件和OR等不同条件下进行时,仍然缺乏数据进行比较。方法:比较不同地区成人肿瘤患者化疗口植入术后并发症类型及发生率,探讨化疗口植入术的安全性。在375名接受化疗端口植入的患者中,203名患者由放射科医生在IR套房进行化疗端口植入,172名患者由普通外科医生在手术室进行手术。对两组患者的早期和晚期死亡率进行了调查。比较早期和晚期并发症的类型和发生率,并与文献结果进行比较。结果:两组患者特征无明显差异。手术后死亡率OR组为39,IR组为72 (P < 0.01)。IR组7天早期死亡率为1例,OR组无一例(P = 0.36)。两组间导管问题发生率无统计学差异(1.16% vs. 0.49%, P = 0.47)。静脉血栓形成4例,静脉血栓形成7例(2.33%比3.45%,P = 0.13);中心静脉血流感染5例,静脉血栓形成6例(2.91%比0.13)。2.96%, P = 0.98)。皮肤问题6例和7例(3.49% vs. 3.45%, P = 0.98)。两组共发生Port site感染6例(3.49% vs. 2.96%, P = 0.77)。结论:化疗口植入术在OR或IR下均可进行,并发症发生率无差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparison of outcomes for chemo-port implantation performed in the operating room and interventional radiology suite: a retrospective observational study.

Purpose: Chemo-port insertion is performed by a radiologist or surgeon in an interventional radiology (IR) suite or an operating room (OR). The complication rate is approximately 3%-4%. However, there is still a lack of data for comparison when it is performed in different conditions such as IR suite and OR.

Methods: This study is for the safety of adult cancer patients after chemo-port implantation by comparing postoperative complication types and rates in different places. Among 375 patients who underwent chemo-port implantation, 203 patients underwent chemo-port implantation by radiologists in an IR suite, and 172 patients underwent the procedure by general surgeons in an OR. In both groups, early and late mortality were investigated. Early and late complication types and rates were also compared, and our study results were compared to the literature.

Results: Patients' characteristics showed no differences. Mortality after the procedure was 39 in OR vs. 72 in IR (P < 0.01). Early mortality at 7 days was 1 in IR, no patient in OR (P = 0.36). Catheter problems did not show a statistical difference in these 2 groups (1.16% vs. 0.49%, P = 0.47). Venous thrombosis happened in 4 and 7 (2.33% vs. 3.45%, P = 0.13), and the central line bloodstream infection was in 5 patients and 6 patients (2.91% vs.. 2.96%, P = 0.98), respectively. Skin problems were 6 and 7 (3.49% vs. 3.45%, P = 0.98). Port site infection happened in 6 patients in each group (3.49% vs. 2.96%, P = 0.77).

Conclusion: Chemo-port implantation can be performed in OR or IR without difference in complication rates.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.30
自引率
7.10%
发文量
75
期刊介绍: Manuscripts to the Annals of Surgical Treatment and Research (Ann Surg Treat Res) should be written in English according to the instructions for authors. If the details are not described below, the style should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publications available at International Committee of Medical Journal Editors (ICMJE) website (http://www.icmje.org).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信